Two Sigma Advisers
OM icon

Two Sigma Advisers’s Outset Medical OM Stock Holding History

Two Sigma Advisers’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-44,869
Closed -$634K – 2543
2025
Q3 		$634K Buy
44,869
+23,294
+108% +$363K ﹤0.01% 1664
2025
Q2 		$414K Buy
+21,575
New +$337K ﹤0.01% 1833
2025
Q1 		– Sell
-27,500
Closed -$458K – 2531
2024
Q4 		$458K Buy
27,500
+507
+2% +$6.33K ﹤0.01% 1808
2024
Q3 		$274K Buy
26,993
+9,020
+50% +$268K ﹤0.01% 1947
2024
Q2 		$1.04M Sell
17,973
-13,814
-43% -$677K ﹤0.01% 1537
2024
Q1 		$1.06M Buy
31,787
+22,374
+238% +$1.13M ﹤0.01% 1562
2023
Q4 		$764K Sell
9,413
-280
-3% -$22.8K ﹤0.01% 1752
2023
Q3 		$1.58M Sell
9,693
-5,080
-34% -$1.2M ﹤0.01% 1316
2023
Q2 		$4.85M Buy
14,773
+4,360
+42% +$1.33M 0.01% 792
2023
Q1 		$2.87M Buy
+10,413
New +$3.82M 0.01% 1071

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Two Sigma Advisers's OM Position: Q4 2025 in Review

Two Sigma Advisers sold out of Outset Medical (OM) in Q4 2025, closing a stake of 44,869 shares — an estimated $634K sold.

Two Sigma Advisers first reported a position in OM in Q1 2023 and held it in 10 quarters. The position peaked at $4.85M in Q2 2023. 100 funds tracked by Wall St. Rank hold OM as of Q4 2025.

  • Two Sigma Advisers reported no remaining Outset Medical position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 44,869 Outset Medical shares in Q4 2025, an estimated $634K.
  • Two Sigma Advisers first reported a position in Outset Medical in Q1 2023 and held it in 10 quarters.
  • Two Sigma Advisers's Outset Medical position peaked at $4.85M in Q2 2023.
  • 100 funds tracked by Wall St. Rank held Outset Medical as of Q4 2025.

Based on Two Sigma Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.